Sulfamethoxazole/Trimethoprim/Pentoxyverine Citrate/Bromhexine Hydrochloride

磺胺甲噁唑/甲氧苄啶/枸橼酸喷托维林/盐酸溴己新

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSulfamethoxazole/Trimethoprim/Pentoxyverine Citrate/Bromhexine Hydrochloride

Drug Alias NamePediatric Pentoxyverine Citrate Sulfamethoxzaole Bromhexine Hydrochloride and Trimethoprim Tablets小儿枸磺新啶片Pentoxyverine Citrate Sulfamethoxazole Bromhexine Hydrochloride and Trimethoprim Tablets枸磺新啶片

ClassificationSmall molecules

Mechanisms of ActionDihydropteroate synthase inhibitorsDihydrofolate reductase inhibitors

TargetsDihydropteroate synthaseDihydrofolate reductase

Therapy Area/IndicationsRespiratory Tract Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsYes Sulfamethoxazole Trimethoprim Pentoxyverine Citrate

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsRespiratory Tract Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A